Current with legislation from the 2023 Regular and Special Sessions signed by the Governor as of November 21, 2023.
Section 51.0005 - Reimbursement Status As Inducement Reimbursement to a subject of ancillary costs under the program:
(1) does not constitute an inducement to participate in a cancer clinical trial;(2) is not considered coercion or the exertion of undue influence to participate in a cancer clinical trial; and(3) is meant to accomplish parity in access to cancer clinical trials and remove barriers to participation in cancer clinical trials for financially burdened subjects.Tex. Health and Safety Code § 51.0005
Renumbered from Tex. Health and Safety Code § 50.0005 by Acts 2021, Texas Acts of the 87th Leg. - Regular Session, ch. 915,Sec. 21.001, eff. 9/1/2021.Added by Acts 2019, Texas Acts of the 86th Leg.- Regular Session, ch. 1157,Sec. 2, eff. 9/1/2019.